Recovery With Medication: Why Opioid Treatment Is Not “Replacing One Drug With Another”
For some people, the hardest part of starting treatment for opioid use disorder is not the medication itself. It is what they have heard about it.
A person may be told that taking buprenorphine or methadone means they are “still using,” or that real recovery requires stopping every opioid immediately. Those ideas are common, but they do not match modern addiction medicine.
Opioid use disorder, or OUD, is a treatable medical condition. Medications can reduce withdrawal and cravings, help people stay in treatment, and lower the risk of overdose. The goal is not to create a new addiction. It is to stabilize a condition that can otherwise be difficult and dangerous to manage.
Why Medication Changes the Recovery Picture
Repeated opioid exposure can alter how the brain and body respond to opioids. For a person with OUD, deciding to stop does not immediately erase withdrawal, craving, or the risk of returning to use.
This is where medications for opioid use disorder, often shortened to MOUD, can help.
Rab Nawaz, M.D., medical writer at MyOpioidRecoveryTeam, has described medication treatment in straightforward terms:
“Medication-assisted treatment isn’t a crutch, it’s closer to insulin for diabetes.”
The comparison is useful because treatment is about managing a medical condition and creating enough stability for the person to work on the rest of recovery. Dr. Nawaz has also emphasized that this stability can help people engage in therapy, rebuild relationships, and return to everyday responsibilities.
Three Medicines, Three Different Approaches
There are three FDA-approved medications for OUD: buprenorphine, methadone, and naltrexone. They work differently, which is one reason treatment should be individualized.
Buprenorphine is a partial opioid agonist. It activates opioid receptors less strongly than full agonists and can reduce withdrawal and cravings. Some formulations combine buprenorphine with naloxone.
Methadone is a long-acting full opioid agonist. In carefully managed treatment, it reduces withdrawal and cravings and can help prevent the repeated intoxication and withdrawal cycle associated with short-acting illicit opioids. In the United States, methadone for OUD is generally provided through certified opioid treatment programs.
Naltrexone works differently. It is an opioid antagonist, meaning it blocks opioid receptors rather than activating them. A person generally needs to be opioid-free before starting it because beginning naltrexone too soon can precipitate withdrawal.
The most appropriate medication depends on factors such as medical history, treatment goals, previous treatment experience, and access to care.
The “Substituting One Drug” Myth
Methadone and buprenorphine are opioids, which is one reason this misconception has survived. But classification alone does not tell us how a medication functions in treatment.
John Winhusen, Ph.D., vice chair of addiction sciences at the University of Cincinnati College of Medicine, addressed the misconception directly:
“No, we are not just replacing one drug with another.”
Winhusen explains that methadone and buprenorphine have different pharmacologic properties from rapidly acting illicit opioids. When used appropriately, they can stabilize opioid receptors, reduce withdrawal and craving, and allow people to function without the repeated highs and lows associated with heroin or fentanyl.
A person taking methadone or buprenorphine as prescribed may develop physical dependence. That means suddenly stopping the medication can cause withdrawal. Physical dependence, however, is not the same as the compulsive pattern of opioid use despite harm that characterizes OUD.
Recovery Does Not Have a Medication Deadline
Some people benefit from medication for months. Others remain on treatment for years. SAMHSA states that medications for OUD can be used for months, years, or even a lifetime when clinically appropriate.
That matters because pressure to taper simply to prove that someone is “really recovered” can put an arbitrary goal ahead of medical stability. Major addiction treatment guidance does not recommend a universal time limit for pharmacologic treatment.
Nora D. Volkow, M.D., director of the National Institute on Drug Abuse, has summarized the evidence clearly:
“Medications for opioid use disorder are safe and effective. They help sustain recovery and prevent overdose deaths.”
Medication does not solve every challenge connected with OUD, but by reducing withdrawal and craving, it can make other health and social problems easier to address.
Where Counseling and Recovery Support Fit
Medication and counseling should not be framed as competitors.
Behavioral therapy can help people identify triggers, develop coping strategies, address coexisting mental health concerns, and strengthen relationships. Peer support, recovery coaching, stable housing, and practical social support can also be valuable.
At the same time, medication should not be withheld simply because a person cannot participate in counseling or does not want a particular form of therapy. Addiction medicine guidance supports pharmacologic treatment even when psychosocial services are unavailable or declined.
Residential rehabilitation can also help some people, but it is not automatically superior to ongoing medication treatment. Recovery plans should reflect the person’s clinical needs rather than a single model of care.
Stopping Treatment Needs Planning Too
Feeling stable on medication can lead someone to wonder whether they still need it. Sometimes reducing or stopping treatment is reasonable, but the decision should be individualized and made with a clinician rather than driven by stigma or a fixed deadline.
Stopping buprenorphine or methadone can lead to withdrawal and may increase the risk of returning to opioid use. After a period of reduced opioid exposure, tolerance falls. Returning to a previously tolerated amount of an illicit opioid can then increase overdose risk.
People with OUD should also have access to naloxone when appropriate. A suspected opioid overdose is a medical emergency. If someone cannot be awakened or is breathing very slowly or not at all, emergency services should be contacted and naloxone given if available.
Medication treatment should also not be replaced by detoxification alone. CDC guidance warns that withdrawal management without medications for OUD can increase the risk of returning to opioid use, overdose, and overdose death.
What Successful Treatment Can Look Like
The most useful question is not whether someone is taking a medication. It is whether treatment is helping them move toward better health and greater stability.
For one person, success may mean stopping illicit fentanyl use, returning to work, and reconnecting with family while taking buprenorphine. For another, it may mean attending a methadone program consistently while rebuilding housing and financial stability. Someone else may prefer extended-release naltrexone after completing opioid withdrawal.
These are different paths, but medication does not make any of them less legitimate.
OUD is a medical condition with effective treatments. Removing the idea that medication is a shortcut or a failure of willpower allows treatment to be judged by what matters most: safety, health, functioning, and sustained recovery.
Medical and Expert Sources
Centers for Disease Control and Prevention, treatment of opioid use disorder and medications for OUD.
U.S. Food and Drug Administration, information about FDA-approved medications for opioid use disorder.
Substance Abuse and Mental Health Services Administration, medication treatment and recovery options for OUD.
Addiction Policy Forum, expert commentary from John Winhusen, Ph.D., on misconceptions surrounding methadone and buprenorphine.
National Institutes of Health, commentary from Nora D. Volkow, M.D., on the safety and effectiveness of medications for OUD.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Opioid treatment should only be used under the supervision of a qualified healthcare professional.